Popular Diets Study
Popular Diets, Metabolism, and CVD Risk
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Children's Hospital Boston
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI ≥ 27 kg/m2
- Willing and able to come to the GCRC 5 days per week to consume a supervised meal and pick-up food for all other meals
- Available for scheduled hospital admissions
- Willing to abstain from alcohol consumption for the duration of the study
- If female, regular menstrual cycles (defined as 26 to 30 days between cycles; no more than one day variation in the duration of menstrual flow)
Exclusion Criteria:
- Weight > 350 lbs
- Change in body weight (± 10%) over preceding year
- Taking any medications or dietary supplements that might affect body weight, appetite, or energy expenditure
- Smoking (1 cigarette in the last week)
- High levels of physical activity
- Currently following a special diet
- Abnormal laboratory screening tests
- Type 2 diabetes mellitus
- Allergies or aversions to foods on the study menu
- Previous diagnosis of an eating disorder or any other mental health disorder
- If female, pregnant in the past 12 months or planning to become pregnant during the study period
- If female, lactating in the preceding 12 months
- If taking birth control medication, change in medication in previous 3 months or plans to change medication during the study period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 2
Low fat diet
|
Feeding protocol, all foods prepared in a metabolic kitchen
|
|
Experimental: 1
Low glycemic index diet
|
Feeding protocol, all foods prepared in a metabolic kitchen
|
|
Active Comparator: 3
Very low carbohydrate diet
|
Feeding protocol, all foods prepared in a metabolic kitchen
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
resting energy expenditure using indirect calorimetry in the fasting state
Time Frame: end of each dietary period
|
end of each dietary period
|
|
insulin resistance assessed by frequently-sampled oral glucose tolerance test
Time Frame: end of each dietary period
|
end of each dietary period
|
|
thyroid function tests
Time Frame: end of each dietary period
|
end of each dietary period
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
total energy expenditure using doubly labeled water methodology
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
thermic effect of food using indirect calorimetry
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
physical activity using accelerometry
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
serum lipids
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
plasminogen activator inhibitor-1
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
C-reactive protein
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
blood pressure
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
hunger/appetite
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
insulin 30 minutes after oral glucose (as an effect modifier)
Time Frame: baseline
|
baseline
|
|
|
Core temperature
Time Frame: End of each dietary period
|
End of each dietary period
|
|
|
secreted frizzle-related protein-4
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
heme-oxygenase
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
Irisin
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
fibroblast growth factor-21
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
chemerin
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
trimethylamine N-oxide
Time Frame: fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
alanine aminotransferase
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
Uric acid
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
insulin
Time Frame: fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
ghrelin
Time Frame: fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
gastric inhibitory peptide
Time Frame: fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
GLP1
Time Frame: fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
PYY
Time Frame: fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
Amylin
Time Frame: fasting and postprandial, end of each dietary period
|
fasting and postprandial, end of each dietary period
|
|
|
Leptin
Time Frame: end of each dietary period
|
end of each dietary period
|
|
|
Metabolomic analysis
Time Frame: end of each dietary period
|
Evaluate the effect of diet on metabolomic profile in plasma, with the aim of assessing dietary adherence and exploring diet-disease mechanisms
|
end of each dietary period
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Cara B Ebbeling, PhD, Boston Children's Hospital
Publications and helpful links
General Publications
- Walsh CO, Ebbeling CB, Swain JF, Markowitz RL, Feldman HA, Ludwig DS. Effects of diet composition on postprandial energy availability during weight loss maintenance. PLoS One. 2013;8(3):e58172. doi: 10.1371/journal.pone.0058172. Epub 2013 Mar 6.
- Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607.
- Hron BM, Ebbeling CB, Feldman HA, Ludwig DS. Hepatic, adipocyte, enteric and pancreatic hormones: response to dietary macronutrient composition and relationship with metabolism. Nutr Metab (Lond). 2017 Jul 5;14:44. doi: 10.1186/s12986-017-0198-y. eCollection 2017.
- Esko T, Hirschhorn JN, Feldman HA, Hsu YH, Deik AA, Clish CB, Ebbeling CB, Ludwig DS. Metabolomic profiles as reliable biomarkers of dietary composition. Am J Clin Nutr. 2017 Mar;105(3):547-554. doi: 10.3945/ajcn.116.144428. Epub 2017 Jan 11. Erratum In: Am J Clin Nutr. 2022 Feb 9;115(2):601.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1R01DK072428 (U.S. NIH Grant/Contract)
- R01DK072428 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.